Cardiac phenotype and angiotensin II levels in AT1a, AT 1b, and AT2 receptor single, double, and triple knockouts

Cardiovascular Research

Volumn 86, Issue 3, 2010, Pages 401-409

  Van Esch, Joep H M ^a   Gembardt, Florian ^b,c   Sterner Kock, Anja ^d   Heringer Walther, Silvia ^e   Le, Thu H ^f   Laßner, Dirk ^g   Stijnen, Theo ^a   Coffman, Thomas M ^f   Schultheiss, Heinz Peter ^e   Danser, A H Jan ^a   Walther, Thomas ^b,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF HULL   (United Kingdom)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g IKDT   (Germany)

Author keywords

Angiotensin II; G protein coupled receptors; Genetically modified animals

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; BRAIN NATRIURETIC PEPTIDE;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; EXTRACELLULAR SPACE; GENE DELETION; GENOTYPE; HEART; HEART BLOOD VESSEL; HEART HEMODYNAMICS; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE SYSTOLIC PRESSURE; HEART MUSCLE; HEART MUSCLE FIBROSIS; HISTOCHEMISTRY; HISTOPATHOLOGY; IN VITRO STUDY; ISOLATED HEART; ISOLATED KIDNEY; KNOCKOUT GENE; MALE; MORPHOLOGY; MOUSE; MUSCLE ATROPHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING;

ANGIOTENSIN II; ANIMALS; ATROPHY; CORONARY CIRCULATION; FIBROSIS; GENOTYPE; KIDNEY; MALE; MICE; MICE, KNOCKOUT; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PERFUSION; PHENOTYPE; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE; VENTRICULAR REMODELING;

EID: 77952368115     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq004     Document Type: Article

References (45)

1. Elton TS, Stephan CC, Taylor GR, Kimball MG, Martin MM, Durand JN et al. Isolation of two distinct type I angiotensin II receptor genes. Biochem Biophys Res Commun 1992; 184:1067-1073.
2. Iwai N, Inagami T, Ohmichi N, Nakamura Y, Saeki Y, Kinoshita M. Differential regulation of rat AT1a and AT1b receptor mRNA. Biochem Biophys Res Commun 1992; 188:298-303.
3. Gembardt F, Heringer-Walther S, van Esch JHM, Sterner-Kock Dvm A, van Veghel R, Le TH et al. Cardiovascular phenotype of mice lacking all three subtypes of angioten-sin II receptors. FASEB J 2008;22:3068-3077.
4. Zou LX, Hymel A, Imig JD, Navar LG. Renal accumulation of circulating angiotensin II in angiotensin II-infused rats. Hypertension 1996;27:658-662. (Pubitemid 26086230)
5. Zou LX, Imig JD, von Thun AM, Hymel A, Ono H, Navar LG. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats. Hypertension 1996;28:669-677. (Pubitemid 26327967)
6. Schuijt MP, van Kats JP, de Zeeuw S, Duncker DJ, Verdouw PD, Schalekamp MADH et al. Cardiac interstitial fluid levels of angiotensin I and II in the pig. J Hypertens 1999; 17:1885-1891.
7. van Kats JP, de Lannoy LM, Danser AHJ, van Meegen JR, Verdouw PD, Schalekamp MADH. Angiotensin II type 1 (AT1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension 1997;30: 42-49.
8. van Kats JP, van Meegen JR, Verdouw PD, Duncker DJ, Schalekamp MADH, Danser AHJ. Subcellular localization of angiotensin II in kidney and adrenal. J Hypertens 2001;19:583-589.
9. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K et al. Angiotensinogen-deficient mice with hypotension. J Biol Chem 1994;269:31334-31337.
10. Gustafson LA, Van Beek JH. Measurement of the activation time of oxidative phos-phorylation in isolated mouse hearts. Am J Physiol Heart Circ Physiol 2000;279: H3118-H3123.
11. Wang QD, Tokuno S, Valen G, Sjoquist PO, Thoren P. Cyclic fluctuations in the cardiac performance of the isolated Langendorff-perfused mouse heart: pyruvate abolishes the fluctuations and has an anti-ischaemic effect. Acta Physiol Scand 2002; 175:279-287.
12. van Esch JHM, Schuijt MP, Sayed J, Choudhry Y, Walther T, Danser AHJ. AT(2) receptor-mediated vasodilation in the mouse heart depends on AT(1A) receptor activation. Br J Pharmacol 2006;148:452-458.
13. Sutherland FJ, Shattock MJ, Baker KE, Hearse DJ. Mouse isolated perfused heart: characteristics and cautions. Clin Exp Pharmacol Physiol 2003;30:867-878.
14. Curtis MJ, Macleod BA, Tabrizchi R, Walker MJ. An improved perfusion apparatus for small animal hearts. J Pharmacol Methods 1986;15:87-94.
15. Stepan H, Walther D, Faber R, Walther T. Detection of C-type natriuretic peptide in fetal circulation. J Perinat Med 2000;28:118-121.
16. Walther T, Klostermann K, Heringer-Walther S, Schultheiss HP, Tschope C, Stepan H. Fibrosis rather than blood pressure determines cardiac BNP expression in mice. Regul Pept 2003;116:95-100.
17. Gembardt F, Sterner-Kock A, Imboden H, Spalteholz M, Reibitz F, Schultheiss HP et al. Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides 2005;26:1270-1277.
18. Walther T, Tschope C, Sterner-Kock A, Westermann D, Heringer-Walther S, Riad A et al. Accelerated mitochondrial adenosine diphosphate/adenosine triphosphate transport improves hypertension-induced heart disease. Circulation 2007;115: 333-344.
19. Padi SS, Chopra K. Selective angiotensin II type 1 receptor blockade ameliorates cyclosporine nephrotoxicity. Pharmacol Res 2002;45:413-420.
20. Danser AHJ, van Kats JP, Admiraal PJJ, Derkx FHM, Lamers JMJ, Verdouw PD et al. Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension 1994;24:37-48.
21. DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978;235:E97-E102.
22. Abdellatif MM, Neubauer CF, Lederer WJ, Rogers TB. Angiotensin-induced desensi-tization of the phosphoinositide pathway in cardiac cells occurs at the level of the receptor. Circ Res 1991;69:800-809.
23. Iglesias AG, Suarez C, Feierstein C, Diaz-Torga G, Becu-Villalobos D. Desensitization of angiotensin II: effect on [Ca2\+]i, inositol triphosphate, and prolactin in pituitary cells. Am J Physiol Endocrinol Metab 2001;280:E462-E470.
24. Reagan LP, Ye X, Maretzski CH, Fluharty SJ. Down-regulation of angiotensin II receptor subtypes and desensitization of cyclic GMP production in neuroblastoma N1E-115 cells. J Neurochem 1993;60:24-31.
25. van Kats JP, Schalekamp MADH, Verdouw PD, Duncker DJ, Danser AHJ. Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int 2001; 60:2311-2317.
26. van Kats JP, Duncker DJ, Haitsma DB, Schuijt MP, Niebuur R, Stubenitsky R et al. Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angioten-sin II. Circulation 2000;102:1556-1563.
27. van Kats JP, Chai W, Duncker DJ, Schalekamp MADH, Danser AHJ. Adrenal angiotensin: origin and site of generation. Am J Hypertens 2005;18:1104-1110.
28. Sakurai K, Norota I, Tanaka H, Kubota I, Tomoike H, Endo M. Negative inotropic effects of angiotensin II, endothelin-1 and phenylephrine in indo-1 loaded adult mouse ventricular myocytes. Life Sci 2002;70:1173-1184.
29. Sekine T, Kusano H, Nishimaru K, Tanaka Y, Tanaka H, Shigenobu K. Developmental conversion of inotropism by endothelin I and angiotensin II from positive to negative in mice. Eur J Pharmacol 1999;374:411-415.
30. Chai W, Garrelds IM, de Vries R, Batenburg WW, van Kats JP, Danser AHJ. Nonge-nomic effects of aldosterone in the human heart: interaction with angiotensin II. Hypertension 2005;46:701-706.
31. Munzenmaier DH, Greene AS. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 1996;27:760-765.
32. Batenburg WW, Garrelds IM, Bernasconi CC, Juillerat-Jeanneret L, van Kats JP, Saxena PR et al. Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation 2004;109:2296-2301.
33. van Esch JHM, Oosterveer CR, Batenburg WW, van Veghel R, Danser AHJ. Effects of angiotensin II and its metabolites in the rat coronary vascular bed: is angiotensin III the preferred ligand of the angiotensin AT(2) receptor? Eur J Pharmacol 2008;588: 286-293.
34. Schupp M, Janke J, Clasen R, Unger T, Kintscher U. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 2004;109:2054-2057.
35. Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 2004;43:993-1002.
36. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ et al. Angio-tensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45: 205-251.
37. Danser AHJ. Local renin-angiotensin systems: the unanswered questions. Int J Biochem Cell Biol 2003;35:759-768.
38. Schuijt MP, Danser AHJ. Cardiac angiotensin II: an intracrine hormone? Am J Hypertens 2002;15:1109-1116.
39. Zhuo JL, Imig JD, Hammond TG, Orengo S, Benes E, Navar LG. Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor. Hypertension 2002;39:116-121.
40. Cook JL, Mills SJ, Naquin R, Alam J, Re RN. Nuclear accumulation of the AT1 receptor in a rat vascular smooth muscle cell line: effects upon signal transduction and cellular proliferation. J Mol Cell Cardiol 2006;40:696-707.
41. Baker KM, Kumar R. Intracellular angiotensin II induces cell proliferation independent of AT1 receptor. Am J Physiol Cell Physiol 2006;291:C995-C1001.
42. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998;83:1182-1191.
43. Ouali R, Berthelon MC, Begeot M, Saez JM. Angiotensin II receptor subtypes AT1 and AT2 are down-regulated by angiotensin II through AT1 receptor by different mechanisms. Endocrinology 1997;138:725-733.
44. Li XC, Zhuo JL. In vivo regulation of AT1a receptor-mediated intracellular uptake of [125I]Val5-ANG II in the kidneys and adrenals of AT1a receptor-deficient mice. Am J Physiol Renal Physiol 2008;294:F293-F302.
45. Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system: a new paradigm. Trends Endocrinol Metab 2007;18:208-214.